1-4 of 4
Marie Lukasova
Close
Sort by
Journal Articles

Progression of Disease within 2 Years Predicts Poor Survival in Patients with Classic Hodgkin Lymphoma

Alexandra Kredátusová, Vit Prochazka, Marie Lukasova, Veronika Hanackova, Tomas Papajik, Veronika Bachanova
Journal: Blood
Blood (2023) 142 (Supplement 1): 6194.
https://doi.org/10.1182/blood-2023-186562
Published: 2023
Journal Articles

Is It Better to Start Treatment with ABVD and Continue with PET2-Adapted Approach or Should We Use 2 Cycles of Beacopp Escalated and 2 Cycles of ABVD and Irradiation in Early Unfavorable Hodgkin Lymphoma?

Heidi Mocikova, Jana Markova, Lubica Gaherova, Maria Maco, Alice Sykorova, David Belada, Marie Lukasova, Vit K Prochazka, Katarina Hradska, Juraj Ďuraš, Ondrej Havranek, Tomas Kozak
Journal: Blood
Blood (2021) 138 (Supplement 1): 4539.
https://doi.org/10.1182/blood-2021-148363
Published: 2021
Journal Articles

Metabolic Tumor Volume and Soluble Cytokines Levels in Newly Diagnosed Hodgkin Lymphoma: What It Brings into the Staging Precision?

VIT K Prochazka, MD, Lenka Henzlova, MD, Marie Lukasova, MD, Veronika Hanackova, MD, Eva Kriegova, Dr, assoc prof, Zuzana Mikulkova, Dr, Gabriela Gabcova, Dr, Jiri Minarik, MD PhD, Alice Sýkorová, MD PhD, Eva Krcalova, MD, Jiri Dolezal, MD assoc prof, Pavel Koranda, MD assoc prof, Tomas Papajik, MD prof
Journal: Blood
Blood (2018) 132 (Supplement 1): 2933.
https://doi.org/10.1182/blood-2018-99-115150
Published: 2018
Journal Articles

Elderly Hodgkin Lymphoma - Multicenter Retrospective Data Analysis from the Czech Hodgkin Lymphoma Registry

Alice Sýkorová, MD PhD, Heidi Mocikova, MD PhD, Vit Prochazka, MD PhD Assoc Prof, Marie Lukasova, MD, Pavla Stepankova, MD, David Belada, MD PhD, Katerina Klaskova, MA, Lubica Gaherova, MD, Karel Chroust, MA, PhD, Jana Markova, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2792.
https://doi.org/10.1182/blood.V130.Suppl_1.2792.2792
Published: 2017